How Much Did iGenetic Diagnostics Raise?
Funding & Key Investors

iGenetic Diagnostics has solidified its position within the Indian healthcare landscape, securing a total capital infusion of $20.5M. This financial trajectory, marked by a recent strategic investment of $19.5M, underscores the company's transition from a specialized diagnostic startup to a major enterprise-level player. By leveraging this capital, the firm continues to expand its footprint in the high-growth molecular and cytogenetic testing sectors, reinforcing its commitment to delivering advanced clinical insights across diverse medical disciplines.

The company's growth narrative is defined by a clear progression, beginning with early-stage backing that facilitated the establishment of its core laboratory infrastructure. The subsequent influx of private equity capital has enabled the firm to scale its operations, effectively bridging the gap between complex pathological research and accessible patient care across its extensive network of collection centers.